Company: SNWV
Filing Date: 2025-09-26
Form Type: 8-K
Source: 0001628280-25-042942
Chunk: 0

Company: SANUWAVE Health, Inc.
Filing Date: 2025-09-26
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item 1.01. Entry into a Material Definitive Agreement.

On September 25, 2025, Sanuwave Health, Inc. (the “ Company”) entered into a credit agreement (the “ Credit Agreement”) among the Company, as a borrower, Sanuwave, Inc., as a guarantor, SanuWave Services, LLC, as a guarantor, the lenders from time to time party thereto and JPMorgan Chase Bank, N. A., as administrative agent (the “ Administrative Agent”). The Credit Agreement provides for a $23.0 million secured term loan (the “ Term Loan”) that matures September 25, 2029 and a $5.0 million secured revolving credit facility (the “ Revolver” and together with the Term Loan, the “ Facility”) that matures September 25, 2027. Availability under the Revolver is subject to a borrowing base composed of eligible accounts receivable. Proceeds of the Facility may be used for working capital and other general corporate purposes and were used at the initial closing, together with cash on hand, to repay all outstanding indebtedness and other obligations under the NWPSA (as defined in Item 1.02 below) and to pay fees and expenses related to the Credit Agreement.

Loans made under the Facility will accrue interest at a rate per annum equal to either, at the Company’s option, a term rate based upon the secured overnight financing rate (“ SOFR”) plus a margin of 3.50% or base rate (generally determined according to the higher of the prime rate and 2.5%) plus a margin of 2.50%. Interest is payable in arrears, in the case of loans bearing interest based on term SOFR, at the end of the applicable interest period, and, in the case of loans bearing interest based on the base rate, quarterly in arrears. Amortization on the Term Loan is payable in equal quarterly installments. The Company may prepay outstanding loans at any time without premium or penalty, subject to customary breakage costs in the case of borrowings bearing interest based on term SOFR.

The Company’s obligations under the Credit Agreement are secured by a lien on substantially all of its and the guarantors’ tangible and intangible assets, including the Company’s equity interests in its subsidiaries.

The Credit Agreement contains customary affirmative and negative covenants that, among other things and subject to certain exceptions, limit the ability of the Company and its subsidiaries to incur additional